News & Event
- Home
- News
- News & Event
On January 18, Ulsan-si announced that Ulsan's mayor, who is on a business trip to the United States leading the city's trade delegation, visited San Diego to establish a foundation for cooperation in the bio industry.
Ulsan's mayor signed an MOU to establish a foundation for cooperation in fostering the bio-industry with San Diego City, UNIST, and the University of California San Diego (UCSD) on January 17 (local time).
According to the MOU, the parties agreed to actively cooperate in ▲ fostering the foundation for industrial cooperation in the bio industry and other fields and ▲ developing digital health technology and supporting the global expansion of bio startups.
The city of San Diego is the second-largest city in California and has advanced science fields such as life science, aerospace, and semiconductors.
In particular, the city is the center of the U.S. bio industry, with 730,000 people working in more than 1,000 bio companies and generating about USD 27 billion in economic effects (as of 2020).
The city is considered one of the top three bio clusters in the USA along with Boston and San Francisco.
It is also a main center in California in the semiconductor sector.
Major semiconductor companies such as Qualcomm, Microchip Technology, and LeapFrog are located in this city.
The UCSD campus is a research-oriented university belonging to the University of California, which is viewed as one of the world's best in bio and biotechnology.
The UCSD has played a major role, such as producing 27 Nobel Prize winners, in developing the city of San Diego into a bio-cluster.
Since last year, Ulsan has played a role role in helping three Ulsan-based companies entering the US market and commercialization through the " Digital Healthcare Global Support Project", jointly promoted by the UNIST and the UCSD.
Thyroscope, a start-up company, is under consideration for USD 10 million investment by U.S. venture capital, while SB-Solution has signed a provisional contract (about 200,000 units per year) with a Hangzhou company, building a bridgehead for entering the Asian market.
DNA Corporation has made achievements such as establishing local partnerships with global medical equipment companies.
hkm@yna.co.kr
Copyrights Yonhap News. All Rights Reserved.
Reprint or redistribution without permission is prohibited.
Source: Yonhap News (January 18, 2024)
** This article was translated from Korean.